These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20516640)

  • 1. Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells.
    Watarai H; Fujii S; Yamada D; Rybouchkin A; Sakata S; Nagata Y; Iida-Kobayashi M; Sekine-Kondo E; Shimizu K; Shozaki Y; Sharif J; Matsuda M; Mochiduki S; Hasegawa T; Kitahara G; Endo TA; Toyoda T; Ohara O; Harigaya K; Koseki H; Taniguchi M
    J Clin Invest; 2010 Jul; 120(7):2610-8. PubMed ID: 20516640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
    Hung JT; Huang JR; Yu AL
    J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NKT cells: their development, mechanisms and effects of action].
    Bojarska-Junak A; Tabarkiewicz J; Roliński J
    Postepy Hig Med Dosw (Online); 2013 Feb; 67():65-78. PubMed ID: 23475484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.
    Huang JR; Tsai YC; Chang YJ; Wu JC; Hung JT; Lin KH; Wong CH; Yu AL
    J Immunol; 2014 Feb; 192(4):1972-81. PubMed ID: 24465013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection.
    Aspeslagh S; Nemčovič M; Pauwels N; Venken K; Wang J; Calenbergh SV; Zajonc DM; Elewaut D
    J Immunol; 2013 Sep; 191(6):2916-25. PubMed ID: 23960235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.
    Parekh VV; Singh AK; Wilson MT; Olivares-Villagómez D; Bezbradica JS; Inazawa H; Ehara H; Sakai T; Serizawa I; Wu L; Wang CR; Joyce S; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3693-706. PubMed ID: 15356115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycolipids injected into the skin are presented to NKT cells in the draining lymph node independently of migratory skin dendritic cells.
    Tripp CH; Sparber F; Hermans IF; Romani N; Stoitzner P
    J Immunol; 2009 Jun; 182(12):7644-54. PubMed ID: 19494288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.
    Sullivan BA; Nagarajan NA; Wingender G; Wang J; Scott I; Tsuji M; Franck RW; Porcelli SA; Zajonc DM; Kronenberg M
    J Immunol; 2010 Jan; 184(1):141-53. PubMed ID: 19949076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cell-derived mice by reprogramming of a mature NKT cell.
    Ren Y; Dashtsoodol N; Watarai H; Koseki H; Quan C; Taniguchi M
    Int Immunol; 2014 Oct; 26(10):551-61. PubMed ID: 24854340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution models to evaluate natural killer T cell function in tumor control.
    Gebremeskel S; Slauenwhite D; Johnston B
    Immunol Cell Biol; 2016 Jan; 94(1):90-100. PubMed ID: 26095148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKT cell responses to glycolipid activation.
    Tefit JN; Davies G; Serra V
    Methods Mol Biol; 2010; 626():149-67. PubMed ID: 20099127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective suppression of tumor growth and hepatic metastasis of neuroblastoma by NKT-stimulatory phenyl glycolipid.
    Wu TN; Hung JT; Hung TH; Wang YH; Wu JC; Yu AL
    Biomed Pharmacother; 2024 Aug; 177():117040. PubMed ID: 38959605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT and tolerance.
    Diana J; Beaudoin L; Gautron AS; Lehuen A
    Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer T cell activation increases iNOS
    Paul S; Chhatar S; Mishra A; Lal G
    J Immunother Cancer; 2019 Aug; 7(1):208. PubMed ID: 31387637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.
    Joshi SK; Lang GA; Larabee JL; Devera TS; Aye LM; Shah HB; Ballard JD; Lang ML
    PLoS Pathog; 2009 Sep; 5(9):e1000588. PubMed ID: 19779559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells.
    Kenna T; Golden-Mason L; Porcelli SA; Koezuka Y; Hegarty JE; O'Farrelly C; Doherty DG
    J Immunol; 2003 Aug; 171(4):1775-9. PubMed ID: 12902477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of natural killer T cells in antitumor immunotherapy.
    Hong C; Park SH
    Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional differences between NKT cells colonizing splanchnic and peripheral lymph nodes.
    Laloux V; Beaudoin L; Ronet C; Lehuen A
    J Immunol; 2002 Apr; 168(7):3251-8. PubMed ID: 11907079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.